UXENDON CRESCENT SURGERY
1 UXENDON CRESCENT, WEMBLEY
AF007
In those patients with atrial fibrillation with a record of a CHA2DS2-VASc score of 2 or more, the percentage of patients who are currently treated with anticoagulation drug therapy
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| AF 6 | 2013 | 16 | 17 | 94.1% | |
| AF003 | 2014 | 14 | 14 | 100.0% | |
| AF005 | 2015 | 14 | 14 | 100.0% | |
| AF007 | 2016 | 43 | 57 | 75.4% | |
| AF007 | 2017 | 62 | 73 | 84.9% | |
| AF007 | 2018 | 66 | 74 | 89.2% | |
| AF007 | 2019 | 73 | 80 | 91.2% | |
| AF007 | 2020 | 87 | 88 | 98.9% | |
| AF007 | 2021 | 85 | 93 | 91.4% | |
| AF007 | 2022 | 90 | 96 | 93.8% | |
| AF007 | 2023 | 76 | 80 | 95.0% |
